Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Board/Management Information 2023

Jul 17, 2023

3538_rns_2023-07-17_486b913e-0e65-48b5-845e-b4320f65c7ee.html

Board/Management Information

Open in viewer

Opens in your device viewer

ArcticZymes Technologies appoints new CEO

ArcticZymes Technologies appoints new CEO

(Tromsø 17 July 2023) ArcticZymes Technologies ASA (OSE:AZT) is pleased to

announce the appointment of Michael Akoh as its new Chief Executive Officer.

Michael is an accomplished business executive with strong leadership experience,

and an established reputation in the life sciences sector. He has over 20+ years

of international experience in general management, business development and

commercialization within the biopharma industry, including senior roles at

diagnostic, med tech and CRO companies. Michael holds a BSc. (Econ) and a MSc.

in International Marketing and Management from the Copenhagen Business School.

Michael says "I am delighted to have been appointed to lead ArcticZymes. It is a

business with a global presence, a talented team and a strong reputation as an

innovative supplier of novel enzymes. I look forward to engaging with the AZT

team, the Board of Directors and our shareholders and to continue to build AZT

into a world-class enzyme company".

Dr Marie Roskrow, Chairman of the Board added "We are very fortunate to have

engaged Michael as our next CEO. Coulter Partners ran an excellent search

process and we had a number of first-class candidates to choose from.in the end,

it was Michael's leadership experience, strategic approach and enthusiasm that

made him a stand-out. We welcome Michael to AZT and wish him every success".

Michael (https://www.linkedin.com/in/michaelakoh/) will commence his position no

later than 1 November 2023.

For more information, please contact:

ArcticZymes Technologies

Chairman of the Board, Marie Roskrow Tel: +44 (0) 7496 959 743

[email protected]

About ArcticZymes Technologies ASA

ArcticZymes Technologies is a Norwegian life sciences company focused on the

development, manufacturing and commercialization of novel recombinant enzymes

for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.

The company is listed on the Oslo Stock Exchange since 2005 as ArcticZymes

Technologies under the [AZT] ticker. Its headquarters are based in Tromsø,

Norway, at the SIVA Innovation Centre.

For more information, please visit the website: www.arcticzymes.com